X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 53 filers reported holding X4 PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57 | -41.8% | 51,968 | +2.7% | 0.00% | – |
| Q2 2023 | $98 | -90.2% | 50,600 | +37661.2% | 0.00% | – |
| Q2 2021 | $1,000 | -98.3% | 134 | -98.1% | 0.00% | – |
| Q1 2021 | $59,000 | +34.1% | 6,901 | 0.0% | 0.00% | – |
| Q4 2020 | $44,000 | -6.4% | 6,901 | 0.0% | 0.00% | – |
| Q3 2020 | $47,000 | -66.2% | 6,901 | -53.7% | 0.00% | – |
| Q2 2020 | $139,000 | +231.0% | 14,901 | +254.7% | 0.00% | – |
| Q1 2020 | $42,000 | -68.7% | 4,201 | -66.5% | 0.00% | – |
| Q4 2019 | $134,000 | +45.7% | 12,532 | +73.3% | 0.00% | – |
| Q3 2019 | $92,000 | -14.8% | 7,232 | 0.0% | 0.00% | – |
| Q2 2019 | $108,000 | +671.4% | 7,232 | +768.2% | 0.00% | – |
| Q1 2019 | $14,000 | – | 833 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 6,247,500 | $6,809,775 | 2.18% |
| Bain Capital Life Sciences Investors, LLC | 15,960,588 | $17,397,041 | 1.94% |
| Stonepine Capital Management, LLC | 5,273,685 | $5,748,317 | 1.91% |
| NEA Management Company, LLC | 14,986,793 | $16,335,604 | 1.26% |
| Sio Capital Management, LLC | 2,599,003 | $2,832,913 | 0.88% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $365,150 | 0.47% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,973,683 | $2,151,314 | 0.25% |
| Monashee Investment Management LLC | 427,265 | $465,719 | 0.20% |
| Orbimed Advisors | 7,133,515 | $7,775,531 | 0.16% |
| Parkman Healthcare Partners LLC | 800,000 | $872,000 | 0.16% |